Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma
Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma
About this item
Full title
Author / Creator
Guo, Xian-ling , Li, Ding , Sun, Kai , Wang, Jin , Liu, Yan , Song, Jian-rui , Zhao, Qiu-dong , Zhang, Shan-shan , Deng, Wei-jie , Zhao, Xue , Wu, Meng-chao and Wei, Li-xin
Publisher
Berlin/Heidelberg: Springer-Verlag
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer-Verlag
Subjects
More information
Scope and Contents
Contents
Angiogenesis inhibitors have long been considered desirable anticancer agents. However, it was found that many tumors could develop resistance to antiangiogenesis inhibitors. Antiangiogenic therapy results in metabolic stress. Autophagy is an important survival mechanism in cancer cells under metabolic stress; however, it remains unknown if autopha...
Alternative Titles
Full title
Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3611041
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3611041
Other Identifiers
ISSN
0946-2716
E-ISSN
1432-1440
DOI
10.1007/s00109-012-0966-0
